Macquarie Group Ltd
- SEC CIK
- 0001418333
- Latest filing
- Aug 14, 2026
ANIP holding history
Ani Pharmaceuticals Inc in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ANIP overviewAll 13F holders of ANIPFull Q2 2026 holdings
- Shares (Q2 2026)
- 164
- Value
- $13.6K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 164 | $13.6K | <0.1% | +164 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −291,129−100.0% | Sold out | Holders |
| Q3 2025 | 291,129 | $26.7M | <0.1% | −132,588−31.3% | Reduced | Holders |
| Q2 2025 | 423,717 | $27.6M | <0.1% | −25,118−5.6% | Reduced | Holders |
| Q1 2025 | 448,835 | $30.1M | <0.1% | −113,768−20.2% | Reduced | Holders |
| Q4 2024 | 562,603 | $31.1M | <0.1% | +70,956+14.4% | Added | Holders |
| Q3 2024 | 491,647 | $29.3M | <0.1% | +103,570+26.7% | Added | Holders |
| Q2 2024 | 388,077 | $24.7M | <0.1% | +174,178+81.4% | Added | Holders |
| Q1 2024 | 213,899 | $14.8M | <0.1% | −16,163−7.0% | Reduced | Holders |
| Q4 2023 | 230,062 | $12.7M | <0.1% | +230,062 | New | Holders |